These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29230554)

  • 21. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
    Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
    Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
    Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
    Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation.
    Ji Y; Zhu X; Sun H; Tan Y; Ma Z; Ye Q; Sujie A; Tang Z
    Chin Med J (Engl); 2000 Sep; 113(9):852-7. PubMed ID: 11776086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
    Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
    Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.
    Alberti N; Frulio N; Bioulac-Sage P; Laumonier H; Balabaud C; Perez JT; Teixeira FR; Harbonnier N; Trillaud H
    Diagn Interv Imaging; 2014 Jan; 95(1):77-83. PubMed ID: 24139183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: a role for angiopoietin-1.
    Gouw AS; Zeng W; Buiskool M; Platteel I; van den Heuvel MC; Poppema S; de Jong KP; Molema G
    Hepatology; 2010 Aug; 52(2):540-9. PubMed ID: 20683953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
    J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background.
    Yoneda N; Matsui O; Kitao A; Kozaka K; Kobayashi S; Sasaki M; Yoshida K; Inoue D; Minami T; Gabata T
    Radiographics; 2016; 36(7):2010-2027. PubMed ID: 27740898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.
    Taimr P; Bröker MEE; Dwarkasing RS; Hansen BE; de Knegt RJ; De Man RA; IJzermans JNM
    Ultrasound Med Biol; 2017 Oct; 43(10):2144-2150. PubMed ID: 28743375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents.
    Glockner JF; Lee CU; Mounajjed T
    Magn Reson Imaging; 2018 Apr; 47():103-110. PubMed ID: 29221964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
    Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
    Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis.
    Doi N; Tomiyama Y; Kawase T; Nishina S; Yoshioka N; Hara Y; Yoshida K; Korenaga K; Korenaga M; Moriya T; Urakami A; Nakashima O; Kojiro M; Hino K
    Intern Med; 2011; 50(11):1193-9. PubMed ID: 21628934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
    Kim MJ; Rhee HJ; Jeong HT
    AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents.
    Sutherland T; Seale M; Yap K
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):50-5. PubMed ID: 24171783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
    Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
    Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
    Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
    Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.
    Sugimori K; Numata K; Okada M; Nihonmatsu H; Takebayashi S; Maeda S; Nakano M; Tanaka K
    J Med Ultrason (2001); 2017 Jan; 44(1):89-100. PubMed ID: 27771842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.